Investment Thesis
PRO DEX demonstrates strong operational fundamentals with 23.7% revenue growth, expanding margins (18.9% net, 16.6% operating), and robust free cash flow generation of $7.2M. The company maintains a conservative balance sheet (0.34x debt/equity, 3.67x current ratio) with excellent interest coverage, though sustainability concerns exist given the extreme net income spike and modest cash position relative to debt levels.
Strengths
- Strong revenue growth of 23.7% YoY with maintained/expanded profitability margins across gross, operating, and net levels
- Excellent balance sheet quality with conservative leverage (0.34x debt/equity), strong liquidity (3.67x current ratio, 2.14x quick ratio), and comfortable debt service (17.5x interest coverage)
- Positive free cash flow conversion with $7.2M FCF and 12.7% FCF margin, supported by capital-light business model ($280K capex)
Risks
- Extraordinary 5692% YoY net income growth compared to 23.7% revenue growth suggests prior year included substantial losses or one-time charges, raising sustainability questions on normalized profitability
- Modest cash position of $6.6M relative to $15.4M long-term debt creates limited financial cushion despite strong coverage ratios
- Small-cap company ($75M assets) in regulated medical device sector faces execution risk and potential competitive pressures without demonstrated R&D commitment or product pipeline visibility
Key Metrics to Watch
- Revenue growth sustainability and gross margin trends over next 2-3 quarters
- Operating cash flow conversion and free cash flow generation consistency
- Cash accumulation trajectory and long-term debt reduction progress
- Customer concentration risk and retention rates in medical instruments segment
Financial Metrics
Revenue
57.1M
Net Income
10.8M
EPS (Diluted)
$3.27
Free Cash Flow
7.2M
Total Assets
75.0M
Cash
6.6M
Profitability Ratios
Gross Margin
30.2%
Operating Margin
16.6%
Net Margin
18.9%
ROE
23.9%
ROA
14.4%
FCF Margin
12.7%
Balance Sheet & Liquidity
Current Ratio
3.67x
Quick Ratio
2.14x
Debt/Equity
0.34x
Debt/Assets
39.7%
Interest Coverage
17.46x
Long-term Debt
15.4M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T12:25:48.186468 |
Data as of: 2026-03-31 |
Powered by Claude AI